BR112012011960A2 - composição para melhorar a circulação sanguínea contendo extrato de lindera obtusiloba como ingrediente ativo - Google Patents

composição para melhorar a circulação sanguínea contendo extrato de lindera obtusiloba como ingrediente ativo

Info

Publication number
BR112012011960A2
BR112012011960A2 BR112012011960A BR112012011960A BR112012011960A2 BR 112012011960 A2 BR112012011960 A2 BR 112012011960A2 BR 112012011960 A BR112012011960 A BR 112012011960A BR 112012011960 A BR112012011960 A BR 112012011960A BR 112012011960 A2 BR112012011960 A2 BR 112012011960A2
Authority
BR
Brazil
Prior art keywords
blood circulation
active ingredient
extract
lindera obtusiloba
composition
Prior art date
Application number
BR112012011960A
Other languages
English (en)
Inventor
Woong Lim Jee
Kim Jong-Hoon
Sohn Jung-Duk
Lee Jung-Ok
Oak Min-Ho
Lee Seung-Woo
Kang So-Hee
Na Yongho
Oh Youna
Original Assignee
Han Wha Pharma Co Ltd
Yang Ji Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Han Wha Pharma Co Ltd, Yang Ji Chemical Co Ltd filed Critical Han Wha Pharma Co Ltd
Publication of BR112012011960A2 publication Critical patent/BR112012011960A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

composição para melhorar a circulação sanguínea contendo extrato de lindera obtusiloba como ingrediente ativo. uma composição para melhorar a circulação sanguínea é fornecida, a qual compreende um extrato de lindera obtusiloba como ingrediente ativo, e, mais especificamente, a uma composição farmacêutica e a um alimento funcional á saúde para prevenir e tratar transtornos trombóticos através da melhora da circulação sanguínea, os quais compreendem um extrato de lindera obtusiloba como ingrediente ativo. o extrato de lindera obtusiloba da presente invenção e um produto bruto purificado do mesmo podem ser obtidos através de extração usando vários solventes, tais como água, etanol, metanol, butanol, etc. visto que o extrato e o produto bruto purificado não apresentam apenas efeito inibitório excelente sobre a agregação plaquetária induzida por várias induções de agregação in vitro, mas também efeito inibitório excelente sobre a formação rápida de trombo in vivo, eles podem ser úteis para prevenir e tratar doenças causadas por transtornos da circulação sanguínea, tais com tromboembolia, etc.
BR112012011960A 2009-11-20 2010-11-19 composição para melhorar a circulação sanguínea contendo extrato de lindera obtusiloba como ingrediente ativo BR112012011960A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020090112484A KR101039628B1 (ko) 2009-11-20 2009-11-20 생강나무 추출물을 유효성분으로 함유하는 혈행개선 조성물
PCT/KR2010/008182 WO2011062436A2 (ko) 2009-11-20 2010-11-19 생강나무 추출물을 유효성분으로 함유하는 혈행개선 조성물

Publications (1)

Publication Number Publication Date
BR112012011960A2 true BR112012011960A2 (pt) 2017-03-01

Family

ID=44060202

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012011960A BR112012011960A2 (pt) 2009-11-20 2010-11-19 composição para melhorar a circulação sanguínea contendo extrato de lindera obtusiloba como ingrediente ativo

Country Status (9)

Country Link
US (2) US20120301562A1 (pt)
EP (2) EP2687263B1 (pt)
JP (1) JP2013511513A (pt)
KR (1) KR101039628B1 (pt)
CN (1) CN102665747A (pt)
BR (1) BR112012011960A2 (pt)
MX (1) MX2012005635A (pt)
PH (1) PH12016501584B1 (pt)
WO (1) WO2011062436A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101185106B1 (ko) * 2012-02-10 2012-09-21 한국과학기술연구원 생강나무속 식물 추출물을 포함하는 안압 하강용 조성물
KR101405144B1 (ko) * 2012-03-09 2014-06-13 한준섭 혈관질환 예방에 도움이 되는 건강보조식품
WO2014163416A1 (ko) * 2013-04-03 2014-10-09 (주)아모레퍼시픽 (+) 시링가레시놀을 포함하는 수명 연장용 조성물
CN104817601B (zh) * 2015-03-31 2018-04-10 浙江大学 从细梗香草中提取三个黄酮类成分混合体、制剂及其方法
KR101671847B1 (ko) 2015-04-09 2016-11-03 원광대학교산학협력단 땃두릅나무 추출물을 유효성분으로 포함하는 혈전 질환의 예방 또는 치료용 조성물
KR101801612B1 (ko) 2016-04-26 2017-11-27 경상북도(농업기술원생물자원연구소장) 흑생강 추출물을 유효성분으로 함유하는 혈전성 질환의 예방 또는 치료용 약학적 조성물 및 건강 기능 식품
KR102084503B1 (ko) * 2017-08-22 2020-03-04 안동대학교 산학협력단 생강잎 추출물을 유효성분으로 함유하는 혈전증의 예방 또는 치료용 약학적 조성물 및 건강 기능 식품
CN108142768A (zh) * 2017-11-17 2018-06-12 浙江科技学院 一种以乌药叶为主体的固体颗粒及其生产方法
KR102428525B1 (ko) 2020-06-26 2022-08-03 제천한약영농조합법인 은행잎추출물, 홍삼농축액 및 해안소나무껍질추출물을 이용한 리큐르주의 제조방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63196514A (ja) * 1987-02-10 1988-08-15 Takeda Chem Ind Ltd 原虫性疾患の予防治療剤
JPH075469B2 (ja) * 1991-12-13 1995-01-25 ナショナル・サイエンス・カウンシル ジセントリン及びその誘導体の高血圧、脈搏不整疾患、動脈硬化に対する治療用途
JP2007519715A (ja) * 2004-01-31 2007-07-19 キョン キム ケンボナシ抽出物、ダンコウバイ抽出物、またはその混合生薬抽出物を有効成分として含む組成物
KR100586269B1 (ko) * 2004-01-31 2006-06-07 김기영 생강나무 추출물을 유효성분으로 함유하는 조성물
BRPI0607571A2 (pt) * 2005-03-10 2009-09-15 Unigen Pharmaceuticals Inc composição de substáncia compreendida de uma mistura de flavonóides de anel b livre flavanas
CN1739690A (zh) * 2005-09-11 2006-03-01 王浩贵 一种大透骨草外用药
CN1857610A (zh) * 2006-03-10 2006-11-08 陈方标 一种含乌药叶提取物的保健品及其制备方法
CN100594915C (zh) * 2007-08-31 2010-03-24 浙江大学 治疗心脑血管疾病的中药提取物的制备方法及其用途
KR100989093B1 (ko) * 2008-01-18 2010-10-25 한화제약주식회사 생강나무 가지의 추출물을 포함하는 심혈관계 질환의 예방 및 치료용 조성물

Also Published As

Publication number Publication date
WO2011062436A2 (ko) 2011-05-26
EP2510933A2 (en) 2012-10-17
EP2687263B1 (en) 2016-10-19
PH12016501584A1 (en) 2017-02-27
JP2013511513A (ja) 2013-04-04
PH12016501584B1 (en) 2017-02-27
MX2012005635A (es) 2012-10-09
CN102665747A (zh) 2012-09-12
EP2510933B1 (en) 2016-01-27
KR101039628B1 (ko) 2011-06-08
EP2687263A1 (en) 2014-01-22
KR20110055872A (ko) 2011-05-26
WO2011062436A3 (ko) 2011-10-27
US20120301562A1 (en) 2012-11-29
EP2510933A4 (en) 2013-04-17
US20140255529A1 (en) 2014-09-11

Similar Documents

Publication Publication Date Title
BR112012011960A2 (pt) composição para melhorar a circulação sanguínea contendo extrato de lindera obtusiloba como ingrediente ativo
PH12018500284A1 (en) 5-bromo-2,6-di-(1h-pyrazol-1-yl)pyrimidin-4-amine for use in the treatment of cancer
PA8840801A1 (es) Derivaos de dioxa-biciclo[3.2.1]octano-2,3,4-triol
SV2016005206A (es) Derivados novedosos de amino pirimidina
BR112014026703A2 (pt) inibidores de dna-pk
BR112019000528A2 (pt) distribuição mediada por ve de conjugados de proteína de ligação-molécula pequena
CL2008001932A1 (es) Compuestos derivados de 6-cicloamino-3-(piridin-4-il)imidazo[1,2-b]piridazina, inhibidores de cq1epsilon y/o ck1delta; procedimiento de preparacion; composicion farmaceutica que los comprende; y uso en el tratamiento de desordenes del sueno, trastorno del ritmo circadiano, cancer y enfermedad de alzheimer.
BR112014000792A2 (pt) compostos de piperidinila para uso como inibidores da tanquirase
DOP2007000053A (es) Compuestos de tetrahidropiridotienopirimidina y métodos para su empleo
CL2009000349A1 (es) Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer.
WO2012142511A3 (en) Orthomolecular compositions and their use in stabilizing the extracellular matrix
CL2012000185A1 (es) Compuestos derivados de oxazina o oxazepina, inhibidores de bace; composicion farmaceutica que los comprende; combinacion farmaceutica; y su uso para el tratamiento del deterioro cognitivo, neuropatia amiloide, o enfermedad de alzheimer.
CL2008003473A1 (es) Compuestos derivados de fenilpiperidina sustituidos por heterociclos; procedimiento de preparacion; composicion farmaceutica que lo comprende; y uso en el tratamiento del trastorno cardiovasculares, tromboembolicos y tumorales; usos in vitro.
EP3444242A3 (en) Novel benzopyran kinase modulators
UY31236A1 (es) Derivados de la 6-cicloamino-3-(piridazin-4-il)imidazo[1,2-b]-piridazina, su preparacion y su aplicacion en terapéutica
EA201200318A1 (ru) Гетероциклические оксимы
EA201200260A1 (ru) Гетероциклические гидразоны и их применение для лечения рака и воспаления
BR112019004534A2 (pt) análogo de amilina, método para a síntese e composição farmacêutica
BR112015017251A8 (pt) composições farmacêuticas compreendendo doadores de nitroxil, misturas e usos das referidas composições farmacêuticas
UY33889A (es) Dimaleato de 9-[4-(3-cloro-2-fluoro-fenilamino)-7-metoxiquinazolin-6-iloxi]-1,4-diaza-espiro[5 .5]undecan-5-ona, su uso como medicamento y su preparación
CL2008001820A1 (es) Compuestos derivados de aril-isoxasol-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y uso en la preparacion de medicamentos utiles en el tratamiento de trastornos cognitivos y enfermedades relacionadas con alzheimer.
DOP2016000076A (es) Tienouracilcarboxamidas cíclicas y usos de las mismas
BR112015030431A2 (pt) formulação de liberação modificada
UY32829A (es) Derivados de 3-heteroaril-metil-imidazo-[1,2-b]-pirididazin - 6 -ilo
UY28210A1 (es) Derivados de ácido acético sustituido con cicloalquilmetoxi, procedimientos para su preparacion y su uso como farmacos.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 36/54 (2006.01), A23L 33/105 (2016.01), A61P